MENU
+Compare
IRMD
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$59.17
Change
+$0.81 (+1.39%)
Capitalization
557.04M

IRMD iRadimed Corp Forecast, Technical & Fundamental Analysis

a provider of non-magnetic intravenous infusion pump systems

IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for IRMD with price predictions
Jan 08, 2025

IRMD in upward trend: price rose above 50-day moving average on December 19, 2024

IRMD moved above its 50-day moving average on December 19, 2024 date and that indicates a change from a downward trend to an upward trend. In of 52 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 27, 2024. You may want to consider a long position or call options on IRMD as a result. In of 116 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IRMD just turned positive on December 26, 2024. Looking at past instances where IRMD's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IRMD broke above its upper Bollinger Band on January 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.622) is normal, around the industry mean (23.424). P/E Ratio (31.844) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.004) settles around the average of (0.018) among similar stocks. P/S Ratio (8.340) is also within normal values, averaging (41.167).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IRMD is expected to report earnings to fall 5.81% to 40 cents per share on February 06

iRadimed Corp IRMD Stock Earnings Reports
Q4'24
Est.
$0.41
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.01
The last earnings report on October 31 showed earnings per share of 43 cents, beating the estimate of 38 cents. With 50.17K shares outstanding, the current market capitalization sits at 557.04M.
A.I.Advisor
published Dividends

IRMD paid dividends on November 25, 2024

iRadimed Corp IRMD Stock Dividends
А dividend of $0.15 per share was paid with a record date of November 25, 2024, and an ex-dividend date of November 15, 2024. Read more...
A.I. Advisor
published General Information

General Information

a provider of non-magnetic intravenous infusion pump systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1025 Willa Springs Drive
Phone
+1 407 677-8022
Employees
148
Web
https://www.iradimed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSQLX9.890.04
+0.41%
Morgan Stanley Inst International Eq L
HEMSX9.260.03
+0.33%
Janus Henderson Emerging Markets S
FHEAX16.450.03
+0.18%
Fidelity Advisor Real Estate A
MCBAX13.67N/A
N/A
BlackRock Large Cap Focus Value Inv C
SVALX6.01N/A
N/A
Federated Hermes Strategic Value Div R6

IRMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with LUNG. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+1.39%
LUNG - IRMD
41%
Loosely correlated
-2.19%
GKOS - IRMD
40%
Loosely correlated
-0.08%
HBIO - IRMD
40%
Loosely correlated
+0.52%
BLFS - IRMD
37%
Loosely correlated
-1.17%
SGHT - IRMD
36%
Loosely correlated
-0.35%
More